Clinical Trials
18
Active:0
Completed:10
Trial Phases
5 Phases
Phase 1:11
Phase 2:1
Phase 3:2
+2 more phases
Drug Approvals
53
PHILIPPINES:53
Drug Approvals
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
Distribution across different clinical trial phases (18 trials with phase data)• Click on a phase to view related trials
Phase 1
11 (61.1%)Not Applicable
2 (11.1%)Phase 3
2 (11.1%)Phase 4
2 (11.1%)Phase 2
1 (5.6%)A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers
Not Applicable
Recruiting
- Conditions
- Dyslipidemia
- Interventions
- Drug: treatment ADrug: treatment BDrug: treatment C
- First Posted Date
- 2025-09-09
- Last Posted Date
- 2025-09-09
- Lead Sponsor
- Korea United Pharm. Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT07162441
- Locations
- 🇰🇷
H plus Yangji Hospital, Seoul, Gwanak-gu, South Korea
Bioequivalence Study Between UI009 and UIC202005 in Healthy Subjects
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- Korea United Pharm. Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT07110740
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Korea, Republic of
Drug-drug Interaction Study Between UIC201603, and UIC201604
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: UIC201603 and co-administration of UIC201603 and UIC201604Drug: UIC201604 and co-administration of UIC201603 and UIC201604
- First Posted Date
- 2024-08-23
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Korea United Pharm. Inc.
- Target Recruit Count
- 57
- Registration Number
- NCT06568133
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Korea, Republic of
A Study to Compare and Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of UI059 and UIC202201
Phase 1
Not yet recruiting
- Conditions
- Gastro-Intestinal Disorder
- Interventions
- Drug: UIC202201
- First Posted Date
- 2024-05-01
- Last Posted Date
- 2024-05-01
- Lead Sponsor
- Korea United Pharm. Inc.
- Target Recruit Count
- 66
- Registration Number
- NCT06393881
- Locations
- 🇰🇷
Chungbuk national university hospital, Cheongju-si, Chungcheongbuk-do, Korea, Republic of
A Clinical Study to Evaluate the Safety and the Pharmacokinetics of UI068 in Healthy Adult Volunteers Under Fed Conditions
Phase 1
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Drug: administration of UI068Drug: administration of UIC202205, UIC202206
- First Posted Date
- 2023-11-21
- Last Posted Date
- 2023-11-21
- Lead Sponsor
- Korea United Pharm. Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT06141590
- Locations
- 🇰🇷
H plus Yangji Hospital, Seoul, Gwanak-gu, Korea, Republic of
- Prev
- 1
- 2
- 3
- Next
News
No news found